Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
What are the benefits
People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2) should not use GLP-1 receptor agonists because of potential tumor risks observed in animal studies
Researchers use 5-Amino-1MQ to explore NNMT inhibition and its effects on downstream molecular signaling in controlled experimental models
While animal and early human studies indicate possible roles in adipose regulation, the compound remains under investigation across several scientific fields
Often discussed in the context of metabolism, its gaining traction in functional medicine for its role in weight management and metabolic support, akin to well-known peptides like semaglutide and tirzepatide.[4][5] Unlike these GLP-1 agonists, which primarily mimic hormones to regulate appetite, 5-Amino-1MQ targets enzymatic pathways directly, offering a complementary mechanism that doesn't rely on hormonal simulation
US$ 27.78
US$ 24.80
US$ 27.90
US$ 29.53
US$ 21.77
